EC: Regulation (EU) 2019/6 and GDP-regulations on veterinary medicinal products in force
The Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) entered into force on 28 January 2022. It modernises the existing rules on the authorisation and use of veterinary medicines in the European Union (EU).
With new measures for increasing the availability and safety of veterinary medicines it should also enhance EU action against antimicrobial resistance. Regulation (EU) 2019/6 repealed Directive 2001/82/EC. Furthermore, it amended the provisions of Regulation (EU) 726/2004 relating to the authorisation and supervision of veterinary medicines, which currently governs the centralised marketing authorisation procedure for both human and veterinary medicines.
In accordance with Regulation (EU) 2019/6, the European Commission added two standalone GDP regulations to Eudralex Volume 4:
- Commission Implementing Regulation (EU) 2021/1248 on good distribution practice for veterinary medicinal products
- Commission Implementing Regulation (EU) 2021/1280 on good distribution practice for active substances used as starting materials in veterinary medicinal products
The documents are compiled analogously to the GDP guidelines for medicinal products for human use and their active substances. All documents can be found in Eudralex Volume 4.
Source:
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
